 | Edgewise Therapeutics, Inc. | |||
| NMS : EWTX || Location: United States | ||||
$16.2+0.55 (+3.51%) |
0.28 M | 15.6 - 16.33 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 5.724 M |
| March 15, 2024 | 4.485 M |
| Feb. 29, 2024 | 5.462 M |
| Feb. 15, 2024 | 5.134 M |
| Jan. 31, 2024 | 5.399 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.44 | -0.47 | -6.17% |
| 09/30/2023 | -0.40 | -0.41 | -1.51% |
| 06/30/2023 | -0.41 | -0.34 | 16.26% |
| 03/31/2023 | -0.37 | -0.36 | 1.96% |
| 12/31/2022 | -0.34 | -0.31 | 9.54% |
EWTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 93.111M | Shares Float | 51.738M |
| Short Float | 5.724M | Market Cap | 1457.19M |
| Institution ownership | 97.84% | Insider ownership | 0.441% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.57 | Forward EPS | -2.05 |